We’re winding down the year, and while market volatility has picked up a bit due to the Fed’s meeting this week on Tuesday and Wednesday, this has been a stunning one for the broad indices.
Year-to-date, the Dow has rallied a whopping 2,800 points—or just over 21%—and the S&P 500 has climbed about 25%.
And here at Blue Chip Growth and Emerging Growth, we’ve enjoyed some strong outperformance to those already-hefty numbers.
In fact, as calculated by the independent Hulbert Financial Digest, my Blue Chip Growth letter has returned a stunning 30% gain through November.
And the smaller, more nimble companies that we focus on in Emerging Growth have done even better, returning 42.1%. That’s double the Dow!
Looking over our current Buy Lists, I’m even more excited for 2014. That’s because we’re investing in the best-of-the-best companies available—large-caps for Blue Chip, small- and mid-caps for Emerging—and it clearly pays to focus on the crème de la crème.
So if you’re not already a member of our Blue Chip Growth and Emerging Growth communities and are interested in this type of strong outperformance, now is a great opportunity to get on board ahead of the seasonal strength that we typically see in the first quarter of the New Year. Sign up for a six-month test drive of our Blue Chip Growth service here.